New molecular diagnostics business launched in Manchester
The aim of APIS Assay Technologies is to help to realise the clinical and commercial potential of genomic medicine in diagnostic tests and personalisation of treatment.
Read More
Tag: QIAGEN
UK Gov publishes Industrial Strategy
The government is calling two major new investments in the UK by pharma firms a “huge vote of confidence” in its approach to industrial strategy.
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
